Skip to main content

Table 2 Product name and administration

From: A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study

  1. INN International non-proprietary name, SmPC Summary of product characteristics
  2. aWhen any generic drug can be used indicate only the INN Name. The choice of the registered name or brand name used in the trial is at the investigation center discretion
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us